Biolife stock.

View the latest BioLife Sciences Inc. (BLFE) stock price, news, historical charts, analyst ratings and financial information from WSJ.The Takeda ID is your authentication method for interactions with Takeda and gives you access to Takeda Services. Learn moreCurrent. N/A. 1 Month Ago. N/A. 3 Months Ago. N/A. BioLife Sciences Inc. analyst estimates, including BLFE earnings per share estimates and analyst recommendations.BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, …

Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The ingredients of Biolife Keto Gummies are very effective and powerful. They work like a magic potion for the body. The product is made from the purest form of all natural ingredients. It is 100% ...WebOn average, Wall Street analysts predict. that Biolife Solutions's share price could reach $25.50 by Aug 10, 2024. The average Biolife Solutions stock price prediction forecasts a potential upside of 103.84% from the current BLFS share price of $12.51.

Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, 2023 is 13.25.. The all-time high BioLife Solutions stock closing price was 140.00 on December 15, 1992.; The BioLife Solutions 52-week high stock price is 26.89, which is 102.9% …Web

BOTHELL, WA—June 1, 2012—BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, ... the Company and understand that the near-term maturity of debt was seen as an overhang for potential new investors in BioLife stock. The extension of the maturity date until 2016, gives us time and financial flexibility to execute on our current growth ...According to 5 analysts, the average rating for BLFS stock is "Strong Buy." The 12-month stock price forecast is $26.0, which is an increase of 137.44% from the latest price.The healthcare company's stock closed last week at $19.22, then dropped to a 52-week low of $11.82 on Friday. The stock is down more than 34% so far this year. ... So what. BioLife is a cell- and ...WebChg %. Market Cap. Evogene Ltd. -1.07%. $30.17M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial...Analysis of Biolife Solutions Piotroski F Score for 2022 including historical trends for the last ten years

BOTHELL, Wash., Aug. 8, 2019 / PRNewswire / -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that it has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a leading developer of advanced ...

7 ธ.ค. 2563 ... Thomas Girschweiler sold 1600000 shares, an approximate value of $36 million, of the BioLife Solutions' stock to Casdin Capital LLC.

Nov 30, 2023 · BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. BioLife Solutions (NASDAQ:BLFS) recently announced preliminary results for FY2017. The company expects full-year 2017 revenue in the range of $11 million, which would be a gain of 34% from 2016. The solid growth in its revenue was driven by strong results from its worldwide distributors and higher sales to customers in the regenerative …Evogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The healthcare company's stock closed last week at $19.22, then dropped to a 52-week low of $11.82 on Friday. The stock is down more than 34% so far this year. ... So what. BioLife is a cell- and ...21 ก.ย. 2563 ... ... shares of BioLife common stock for 100% of the outstanding shares of SciSafe. SciSafe's shareholders are also eligible over the next four ...Get the latest Biolife Sciences Inc (BLFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.WebNov 28, 2023 · Stock analysis for Biolife Sciences Inc (BLFE:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.BioLife Solutions, Inc. | 6,162 followers on LinkedIn. A leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies | BioLife Solutions is a ...Find the latest GasLog Partners LP (GLOP-PC) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 2, 2023 · BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection.

BIOLYTE® is the only Medical Grade Hydration drink to have the same amount of electrolytes as an IV bag. Our liquid IV helps fight nausea, headaches and fatigue associated with dehydration. With 6.5x more electrolytes than leading sports drinks, BIOLYTE is family owned and on a mission to help people feel better fast.Analysis of Biolife Solutions Piotroski F Score for 2022 including historical trends for the last ten yearsBioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. 2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United StatesStocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more. Notes to Financial Statements Business Combination Disclosure [Text Block] 15. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in …

Nov 9, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.

We are pleased to inform you that by the determination of the Board of Directors of BioLife Solutions, Inc. (the "Company"), a stock option to purchase <quantity> shares of the common stock, par value $.001 per share, of the Company (the "Common Stock"), at the price of $<price> per share, was granted to you on the <day> day of <month>, <year> …

Biolife Solutions story: Acquisition by Duross Amy of 14730 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsBiolife Solutions Return On Asset is currently at (5.67)%. Return on Asset or ROA shows how effective is the management of the Biolife Solutions in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of Biolife Solutions as well as to understand management …Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. Nov 16, 2023 · On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $12.34 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was 10.28%, and its shares lost 41.93% of ... BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.BioLife Solutions Debt Current yearly trend continues to be comparatively stable with very little volatility. Debt Current will likely drop to about 4.2 M in 2023. From the period from 2010 to 2023, BioLife Solutions Debt Current quarterly data regression had r-squared of 0.57 and coefficient of variation of 91.26.At this time, BioLife Solutions' Selling General and …Casdin Capital now owns about 19.5% of BioLife Solutions' stock. BioLife Chief Financial Officer Troy Wichterman said the company didn't have any insight to provide beyond the publicly available ...Exact matches only . Search in title. Search in titleOn average, Wall Street analysts predict. that Biolife Solutions's share price could reach $25.50 by Aug 10, 2024. The average Biolife Solutions stock price prediction forecasts a potential upside of 103.84% from the current BLFS share price of $12.51. BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...

The ingredients of Biolife Keto Gummies are very effective and powerful. They work like a magic potion for the body. The product is made from the purest form of all natural ingredients. It is 100% ...WebCongenital TTP is a life-threatening, rare genetic disorder with debilitating chronic symptoms. Find the latest Takeda Pharmaceutical Company Limited (TAK) stock quote, history, news and other ...BioLife Solutions, Inc. (NASDAQ:BLFS) Major Shareholder Casdin Partners Master Fund, L Acquires 58,465 Shares marketbeat.com - August 11 at 7:16 PM: Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Synlogic (SYBX) markets.businessinsider.com - August 11 at 6:40 PMWebInstagram:https://instagram. track stock portfolio appproperty investment agencyoutside water and sewer line insurancedakota gold corp Story continues Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of …Discover historical prices for BLFS stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Solutions, Inc. stock was issued. cyro cellbud light beer stock In today’s fast-paced world, it can be challenging to stay organized and manage our time effectively. With so many tasks and responsibilities vying for our attention, it’s crucial to have a reliable tool that can help us stay on track. This...BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the three and nine months …Web eiffl BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ...BioLife Solutions (BLFS) (Delayed Data from NSDQ) $13.57 USD -0.06 (-0.44%) Updated Nov 22, 2023 03:59 PM ET After-Market: $13.55 -0.02 (-0.15%) 7:20 PM ET Add to portfolio Zacks Rank: 3-Hold 3...